US Broker Ratings

Viatris Inc. (VTRS) Stock Analysis: Exploring a Potential 26% Upside Amidst Volatility

Viatris Inc. (NASDAQ: VTRS) is a prominent player in the healthcare sector, specifically within the drug manufacturing industry, focusing on both specialty and generic pharmaceuticals. Despite the current market volatility,..

Quest Diagnostics (DGX) Stock Analysis: Revenue Growth Sparks Investor Interest

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, specifically in diagnostics and research, commands a significant market presence with a market capitalization of $19.85 billion. As..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a 45% Potential Upside in the Booming Medical Device Sector

Investors eyeing opportunities in the healthcare sector may find Globus Medical, Inc. (NASDAQ: GMED) an intriguing prospect. With a market capitalization of $7.93 billion, this U.S.-based medical device company is..

BrightSpring Health Services, Inc. (BTSG) Investor Outlook: Analyzing a 19% Potential Upside

BrightSpring Health Services, Inc. (BTSG), a key player in the Health Information Services industry, presents a compelling investment opportunity within the healthcare sector. With a market capitalization of $4.14 billion,..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unpacking a 61% Potential Upside in the Medical Device Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) stands out in the healthcare sector, particularly within the medical devices industry, due to its innovative approach to tackling obstructive sleep apnea (OSA). The..

Guardant Health, Inc. (GH) Stock Analysis: 17% Upside Potential Amidst Strong Buy Ratings

Guardant Health, Inc. (NASDAQ: GH) continues to capture investor attention as it solidifies its position within the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization..

Telix Pharmaceuticals Limited (TLX): Investor Outlook and Potential Upside of Over 42%

Telix Pharmaceuticals Limited (ASX: TLX) is capturing significant attention in the biotechnology sector with its promising portfolio of radiopharmaceuticals aimed at treating cancer and rare diseases. As a commercial-stage biopharmaceutical..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Uncovering a 39.93% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a major player in the healthcare sector, is captivating investor attention with a striking potential upside of nearly 40%. As a global leader in..

Biogen Inc. (BIIB) Investor Outlook: Navigating an Upside of Over 36% Amidst a Challenging Market

For investors eyeing the healthcare sector, Biogen Inc. (NASDAQ: BIIB) presents a compelling opportunity with a potential upside of 36.58%, according to current analyst ratings. With its strong focus on..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Evaluating a 35.81% Potential Upside

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, particularly within the diagnostics and research industry, stands out as a compelling investment opportunity for individual investors seeking..

Neurocrine Biosciences, Inc. (NBIX) Investor Outlook: Strong Buy Ratings and 27.73% Upside Potential

Neurocrine Biosciences, Inc. (NBIX) stands out as a compelling investment opportunity within the healthcare sector, specifically in the niche of drug manufacturing for specialty and generic pharmaceuticals. With a market..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking the 16.10% Upside Potential in Healthcare Innovation

Stevanato Group S.p.A. (NYSE: STVN), a pivotal player in the healthcare sector, is capturing investor attention with its robust market presence and burgeoning growth prospects. With a market capitalization of..

Walgreens Boots Alliance (WBA) Stock Analysis: Dividend Yield Shines Amidst Challenging Valuation Metrics

As Walgreens Boots Alliance, Inc. (NASDAQ: WBA) navigates the complexities of the healthcare sector, investors are taking a close look at its financial health and market positioning. With a market..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 21% Potential Upside in Medical Device Innovation

Integer Holdings Corporation (NYSE: ITGR) is carving its niche in the healthcare sector, providing cutting-edge solutions in the medical devices industry. With a market capitalization of $4.28 billion, Integer Holdings..

Masimo Corporation (MASI) Stock Analysis: Navigating the Market with a 9.23% Upside Potential

Masimo Corporation (NASDAQ: MASI), a key player in the healthcare sector, is capturing attention with its innovative medical devices. The company, based in Irvine, California, has carved a niche in..

iRhythm Technologies, Inc. (IRTC): Investor Outlook on a Leading Digital Healthcare Innovator

For investors keen on the healthcare sector, iRhythm Technologies, Inc. (NASDAQ: IRTC) stands out as a noteworthy player in the realm of medical devices. With a market capitalization of $4.94..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 44.86% Potential Upside in Biotech Innovation

Investors are turning their attention to Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leading biotechnology firm in the healthcare sector, as it continues to make significant strides in RNA-targeted medicines. With..

Cardinal Health, Inc. (CAH) Investor Outlook: A Closer Look at Its 3.01% Upside Potential

Cardinal Health, Inc. (NYSE: CAH) is a significant player in the healthcare sector, primarily focusing on medical distribution. With a robust presence in the United States and internationally, the company..

Chemed Corp (CHE) Stock Analysis: Unlocking a 15.61% Potential Upside in the Healthcare Sector

Chemed Corporation (NYSE: CHE), a notable player in the healthcare sector, is capturing investor attention with its unique dual-segment business model and promising growth potential. With a current market capitalization..

Baxter International Inc. (BAX) Stock Analysis: 26% Upside Potential Amidst Healthcare Sector Dynamics

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, presents an intriguing opportunity for investors with its substantial potential upside. The company’s diverse portfolio of medical instruments and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds